​

DexCom (DXCM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DXCM Stock Forecast

DexCom (DXCM) stock forecast, based on 52 Wall Street analysts, predicts a 12-month average price target of $85.22, with a high of $99.00 and a low of $75.00. This represents a 23.63% increase from the last price of $68.93.

$65 $80 $95 $110 $125 $140 High: $99 Avg: $85.22 Low: $75 Last Closed Price: $68.93

DXCM Stock Rating

DexCom stock's rating consensus is Buy, based on 52 Wall Street analysts. The breakdown includes 1 Strong Buy (1.92%), 41 Buy (78.85%), 9 Hold (17.31%), 1 Sell (1.92%), and 0 Strong Sell (0.00%).

Buy
Total 52 9 41 1 Strong Sell Sell Hold Buy Strong Buy

DXCM Price Target Upside V Benchmarks

TypeNameUpside
StockDexCom23.63%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.58%

Price Target Trends

1M3M12M
# Anlaysts11212
Avg Price Target$75.00$85.00$85.00
Last Closing Price$68.93$68.93$68.93
Upside/Downside8.81%23.31%23.31%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 254205--29
Nov, 254204--28
Oct, 254194--27
Sep, 253204--27
Aug, 253194--26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2025Patrick WoodMorgan Stanley$75.00$63.5218.07%8.81%
Nov 10, 2025Morgan Stanley$63.00$55.2114.11%-8.60%
Nov 03, 2025Lee HambrightBernstein$84.00$58.2244.28%21.86%
Nov 03, 2025Barclays$80.00$58.2237.41%16.06%
Oct 31, 2025Matt O'BrienPiper Sandler$75.00$56.9731.65%8.81%
Oct 31, 2025RBC Capital$85.00$56.9549.25%23.31%
Oct 31, 2025Robert W. Baird$82.00$59.1938.54%18.96%
Oct 31, 2025Wells Fargo$93.00$68.2036.36%34.92%
Oct 31, 2025William PlovanicCanaccord Genuity$99.00$68.2045.16%43.62%
Oct 21, 2025Matt O'BrienPiper Sandler$100.00$68.4446.11%45.07%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2025CitigroupBuyBuyhold
Dec 02, 2025Morgan StanleyEqual-WeightOverweightupgrade
Nov 03, 2025BernsteinOutperformOutperformhold
Oct 31, 2025Piper SandlerBuyBuyhold
Oct 24, 2025Cowen & Co.BuyBuyhold
Oct 21, 2025Piper SandlerOverweightOverweighthold
Sep 08, 2025OppenheimerOutperformPerformdowngrade
May 22, 2025CitigroupBuyBuyhold
May 02, 2025Piper SandlerOverweightOverweighthold
Mar 08, 2025Wells FargoOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.31$0.56$0.88$1.40-----
Avg Forecast$0.76$0.71$0.80$1.44$1.69$2.02$2.45$3.11$3.85
High Forecast$0.78$0.73$0.81$1.48$1.74$2.19$2.77$3.26$3.89
Low Forecast$0.75$0.69$0.78$1.40$1.60$1.79$2.01$2.95$3.82
Surprise %72.37%-21.13%10.00%-2.78%-----

Revenue Forecast

$2B $3B $4B $5B $6B $8B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.93B$2.45B$2.91B$3.62B-----
Avg Forecast$1.91B$2.45B$2.91B$3.60B$4.02B$4.61B$5.31B$6.26B$7.15B
High Forecast$1.95B$2.50B$2.93B$3.63B$4.03B$4.65B$5.31B$6.30B$7.21B
Low Forecast$1.88B$2.41B$2.87B$3.58B$4.00B$4.59B$5.30B$6.22B$7.11B
Surprise %0.73%-0.00%0.16%0.56%-----

Net Income Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$493.60M$154.70M$341.20M$541.50M-----
Avg Forecast$469.89M$108.96M$212.70M$541.50M$680.80M$779.93M$954.91M$1.32B$1.64B
High Forecast$563.87M$140.14M$265.56M$676.08M$739.43M$931.55M$1.18B$1.39B$1.65B
Low Forecast$375.91M$77.78M$159.84M$406.92M$679.93M$759.83M$856.02M$1.26B$1.63B
Surprise %5.05%41.98%60.41%------

DXCM Forecast FAQ

Is DexCom stock a buy?

DexCom stock has a consensus rating of Buy, based on 52 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 41 Buy, 9 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that DexCom is a favorable investment for most analysts.

What is DexCom's price target?

DexCom's price target, set by 52 Wall Street analysts, averages $85.22 over the next 12 months. The price target range spans from $75 at the low end to $99 at the high end, suggesting a potential 23.63% change from the previous closing price of $68.93.

How does DexCom stock forecast compare to its benchmarks?

DexCom's stock forecast shows a 23.63% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.58%).

What is the breakdown of analyst ratings for DexCom over the past three months?

  • December 2025: 13.79% Strong Buy, 68.97% Buy, 17.24% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 14.81% Strong Buy, 70.37% Buy, 14.81% Hold, 0% Sell, 0% Strong Sell.

What is DexCom’s EPS forecast?

DexCom's average annual EPS forecast for its fiscal year ending in December 2024 is $1.69, marking a 20.71% increase from the reported $1.4 in 2023. Estimates for the following years are $2.02 in 2025, $2.45 in 2026, $3.11 in 2027, and $3.85 in 2028.

What is DexCom’s revenue forecast?

DexCom's average annual revenue forecast for its fiscal year ending in December 2024 is $4.02B, reflecting a 11.04% increase from the reported $3.62B in 2023. The forecast for 2025 is $4.61B, followed by $5.31B for 2026, $6.26B for 2027, and $7.15B for 2028.

What is DexCom’s net income forecast?

DexCom's net income forecast for the fiscal year ending in December 2024 stands at $680.8M, representing an 25.72% increase from the reported $541.5M in 2023. Projections indicate $779.93M in 2025, $954.91M in 2026, $1.32B in 2027, and $1.64B in 2028.